Learning Objectives:
1. Interpret the role of a-synuclein prion strains in the pathogenesis, phenotypic spectrum and disease progression in Parkinson’s disease
2. Recognize the spectrum of proteins involved beyond a-synuclein in the pathogenesis of Parkinson’s disease
3. Interpret the relevance of mixed pathologies in patient selection and clinical trial design